Corpay: The Math and the Price Agree, and That's the Point

Corpay just delivered a record quarter. Revenue of $1.34 billion — up 21% from a year ago and $45 million above Wall Street's forecast. Adjusted cash EPS hit $7.00, a company first and a 36% jump year over year. Management raised full-year guidance to $5.31 billion in revenue and $27.35 in cash EPS. The stock is up roughly 39% so far this year and sits at about $417.

The number to look at next is the PEG ratio: 2.14.

A PEG of 2.14 means the stock trades at 24 times trailing earnings while growing revenue at roughly 20%. The price multiple is more than double the growth rate. In growth-at-a-reasonable-price terms, "reasonable" typically means a PEG near 1.0 or below. Corpay is not trading at a reasonable price. It is trading at a premium one. And that premium matters because the market has already answered the question most investors are asking: is this company growing? Yes. The question now is whether the price leaves any margin of error if that growth slows.

Corpay, formerly FleetCor until a 2024 rebrand, is not a consumer payment card company. It operates three specialized B2B payment workflows: vehicle payments for commercial fleets (fuel, tolls, maintenance, and increasingly EV charging), corporate payments (accounts payable automation, virtual cards, and cross-border foreign exchange), and lodging payments for workforce housing and insurance-displacement travel. The model is recurring and transaction-driven — fees, spreads, network economics, and platform charges rather than one-time licenses. Once embedded in a company's ERP and treasury systems, switching costs are high. Customer retention sits at 93%. New bookings grew 30% year over year in the second quarter.

This is a business that grows through specialization and bolt-on acquisitions — Comdata, Cambridge Global Payments, AFEX, ALE Solutions — and it prints real margins. The trailing operating margin is 46%. EBITDA margin is 55%. Those numbers look more like a software company than a payments processor, and that's by design: the workflow software and controls around the payment rail are where the defensibility lives.

But Corpay is not a software company either. Its free cash flow fell 15% year over year to $1.64 billion on a trailing twelve-month basis. The decline reflects operating cost growth of 9%, rising credit losses, and the weight of integrating acquisitions like Alpha, which is about 80% complete. Capital expenditures came in at roughly $209 million TTM. The business generates cash, but the cost of growing it is visible.

Management's 2029 target is the number that matters for anyone considering the stock at this level. The company's mid-term roadmap projects cash EPS of approximately $50 per share by 2029 — a greater-than-20% compound annual growth rate from the 2026 midpoint. Revenue is modeled to reach $7.1 billion, from $5.31 billion this year, implying 10% annual organic growth. Cash profit before tax would expand from $2.4 billion to $3.5 billion.

The math behind the $50 target rests on three levers: operational growth at 10%, margin expansion as the corporate payments mix increases, and aggressive share repurchases funded by both free cash flow and incremental debt. Management plans to add $3 to $4 billion in absolute debt over the mid-term while maintaining a roughly constant leverage ratio. That's on top of $24.3 billion in total debt already outstanding, with net debt of $7.46 billion and a leverage ratio of 2.55x. The company extended and upsized its credit facility by $1.3 billion in May 2026.

There's nothing wrong with this plan. Plenty of successful companies use debt to finance buybacks while growing organically. The question is whether the assumptions hold and whether the current price leaves room for one of them to fail.

At $417 and a market cap of $27.4 billion, the stock implies that $50 by 2029 is not just achievable — it's expected. If you annualize the return required to make the current price fair at $50 in three years, the market is demanding roughly 17-18% EPS growth without any multiple expansion. That's below management's >20% target, which means the market is actually being somewhat conservative. But it also means that any slowdown in the growth rate — from 10% organic revenue growth to, say, 6-7% — would require a meaningful multiple contraction to keep the stock flat.

For context, Corpay's closest diversified peer, WEX, trades at a P/E of roughly 19.7 — not 24. WEX's EV/EBITDA is about 7.0, compared to Corpay's 13.2. WEX is a smaller, slower company. But the multiple gap is roughly what you'd pay for a company that compounds at 20%+ while the peer compounds at 10%. The market is paying for the difference, and it's asking you to believe the difference persists.

The second-quarter results contained an important detail that most headlines skipped. Management acknowledged that roughly two-thirds of the revenue beat came from favorable macro conditions — foreign exchange tailwinds, fuel price spreads — rather than pure operational outperformance. The organic revenue growth, which strips out acquisitions and currency, was 10%. Corporate Payments grew 16% organically but absorbed an 180 basis point drag from float revenue compression as interest rates fell. Same-store sales turned barely positive at 1%.

This is not a bear case. A 10% organic growth rate with 46% operating margins is still excellent. But it's useful to know what's driving the beat: a mix of genuine momentum (new bookings at 30% growth, the corporate payments cross-sell taking hold, EV charging expansion) and cyclical tailwinds. When macro tailwinds reverse, and they always do, the company is growing into a stock that has already run 39% for the year.

There's a regulatory item too. Corpay recorded a $100 million charge in Q2 for a preliminary settlement with the Federal Trade Commission, still awaiting final approval later this year. The underlying case found Corpay liable for deceptive advertising — advertised fuel discounts that fine-print disclaimers effectively nullified, "fuel only" cards that could buy gift cards and snacks, and unauthorized add-on fees charged to customers who never consented. A permanent injunction bars those practices going forward. The $100 million charge was excluded from adjusted earnings, which is standard for settlements, but the injunction is real and the compliance cost is real. The 11th Circuit affirmed the ruling on four of five counts. CEO Ron Clarke was personally found liable on three of them. This isn't existential — the charge is one-time and the business model is intact — but it's a reminder that this company operated in a regulatory gray area for years and that the compliance overhaul is just beginning.

So where does this leave an investor?

Corpay is not a stock that the market has misread. The math is solid, the execution is real, and the growth trajectory is legitimate. The company raised guidance after a record quarter, and the segments are behaving the way management described they would.

But the stock is also not cheap. A PEG of 2.14, a P/E of 24 against a peer trading at 19.7, and an EV/EBITDA of 13.2 are not the multiples of a company whose upside is obvious. The market has done its work already. The question for a new investor isn't whether Corpay can grow — it's whether the growth can continue at a rate that justifies a premium multiple three years from now, when the stock needs to reach that $50 EPS target without relying on multiple expansion to stay flat.

The setup that would justify this price is simple: 10% organic revenue growth continues, the corporate payments segment scales as planned, margin expansion proceeds, and the buyback program compounds EPS. Management has a track record of meeting guidance, and the backlog of new bookings at 30% growth suggests the pipeline is deep. If that executes, the stock has room to run toward the mid-term target.

The risk is equally simple: organic growth slows, the macro tailwinds that boosted Q2 reverse, or the incremental debt strategy encounters headwinds in a higher-rate environment. Any of those scenarios doesn't break the business — Corpay's margins and cash generation are too strong for that — but they do compress the multiple. And at a 24x P/E, there's limited cushion on the downside.

This is not a buy because the stock is cheap. It's a buy — for the right investor — only if you believe the 10%+ organic growth and margin expansion will hold through 2029 and you're comfortable owning the stock at a premium to its peers. If you're looking for a disconnect between the math and the price, Corpay isn't it. The price and the math agree. The question is whether you agree with them both.